CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients.
PLoS One
; 17(5): e0268530, 2022.
Article
in En
| MEDLINE
| ID: mdl-35613127
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cytomegalovirus Infections
/
COVID-19
/
Herpes Simplex
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Humans
Language:
En
Journal:
PLoS One
Journal subject:
CIENCIA
/
MEDICINA
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: